Additional file 3: of Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

Autor: Vandenberghe, Rik, Rinne, Juha, Boada, Mercè, Katayama, Sadao, Scheltens, Philip, Vellas, Bruno, Tuchman, Michael, Gass, Achim, Fiebach, Jochen, Hill, Derek, Lobello, Kasia, Li, David, McRae, Tom, Lucas, Prisca, Evans, Iona, Booth, Kevin, Luscan, Gerald, Wyman, Bradley, Hua, Lisa, Lingfeng Yang, H. Brashear, Black, Ronald
Rok vydání: 2016
Předmět:
DOI: 10.6084/m9.figshare.c.3603020_d6
Popis: Prespecified outcomes in apolipoprotein E ε4 carrier and noncarrier trials. All prespecified endpoints are listed. (DOCX 18 kb)
Databáze: OpenAIRE